Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8354 items from SEC EDGAR · clear filters
- 8-K - CG Oncology, Inc. (0001991792) (Filer)
Automated noteCG Oncology, Inc. submitted a Form 8-K on August 6, 2026 (Accession No. 0001193125-26-336886), containing Item 2.02 results of operations and financial condition, Item 8.01 other events, and Item 9.01 financial statements and exhibits.
- 8-K - Arteris, Inc. (0001667011) (Filer)
Automated noteArteris, Inc. filed a Form 8-K on August 6, 2026, reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Vystar Corp (0001308027) (Filer)
Automated noteVystar Corp filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - MAXIMUS, INC. (0001032220) (Filer)
Automated noteMaximus Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits. The filing, accession number 0001032220-26-000033, is 661 KB.
- 8-K - ONCOR ELECTRIC DELIVERY CO LLC (0001193311) (Filer)
Automated noteOncor Electric Delivery Co LLC filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)
Automated noteEnsysce Biosciences filed an 8-K reporting entry into a material definitive agreement, completion of an asset acquisition/disposition, unregistered equity sales, modifications to security holder rights, changes in directors/officers and compensation, and amendments to its charter and fiscal year.
- 8-K - Annexon, Inc. (0001528115) (Filer)
Automated noteAnnexon, Inc. filed a Form 8-K on August 6, 2026, reporting other events under Item 8.01 and providing its financial statements and related exhibits under Item 9.01.
- 8-K - CRA INTERNATIONAL, INC. (0001053706) (Filer)
Automated noteCRA International, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Automated noteCorbus Pharmaceuticals Holdings filed a Form 8-K on August 6, 2026, containing Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).
- 8-K - Vivani Medical, Inc. (0001266806) (Filer)
Automated noteVivani Medical, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - HELIX ENERGY SOLUTIONS GROUP INC (0000866829) (Filer)
Automated noteHelix Energy Solutions Group Inc filed a Form 8-K on August 6 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.
- 8-K - Edgewise Therapeutics, Inc. (0001710072) (Filer)
Automated noteEdgewise Therapeutics filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - VivoSim Labs, INC. (0001497253) (Filer)
Automated noteVivoSim Labs, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)
Automated noteALX Oncology Holdings Inc filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - LIFETIME BRANDS, INC (0000874396) (Filer)
Automated noteLifetime Brands filed an 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits.
- 8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)
Automated noteEstablishment Labs Holdings Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 reporting its results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.
- 8-K - ACI WORLDWIDE, INC. (0000935036) (Filer)
Automated noteACI Worldwide, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - MBX Biosciences, Inc. (0001776111) (Filer)
Automated noteMBX Biosciences, Inc. filed an 8-K on August 6, 2026, containing Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).
- 8-K - INSIGHT ENTERPRISES INC (0000932696) (Filer)
Automated noteInsight Enterprises Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.
- 8-K - NOVAVAX INC (0001000694) (Filer)
Automated noteNovavax Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.
- 8-K - Aurinia Pharmaceuticals Inc. (0001600620) (Filer)
Automated noteAurinia Pharmaceuticals filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Prime Medicine, Inc. (0001894562) (Filer)
Automated notePrime Medicine, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing financial statements and related exhibits (Item 9.01).
- 8-K - Globalstar, Inc. (0001366868) (Filer)
Automated noteGlobalstar, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - USA TODAY Co., Inc. (0001579684) (Filer)
Automated noteUSA TODAY Co., Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing related financial statements and exhibits.
- 8-K - HERTZ CORP (0000047129) (Filer)
Automated noteHertz Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Filer)
Automated noteHertz Global Holdings, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - NextTrip, Inc. (0000788611) (Filer)
Automated noteNextTrip, Inc. filed a Form 8-K on August 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Playtika Holding Corp. (0001828016) (Filer)
Automated notePlaytika Holding Corp. filed a Form 8-K on August 6, 2026, reporting its results of operations, financial condition, and providing financial statements and related exhibits.
- 8-K - Guerrilla RF, Inc. (0001832487) (Filer)
Automated noteGuerrilla RF, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - Aligos Therapeutics, Inc. (0001799448) (Filer)
Automated noteAligos Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.